|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
OpGen, Inc. Release: Optical Mapping First to Definitively Determine Deadly E. coli Strains in German Outbreak Are From a Single Source and Related to Earlier Outbreaks
6/13/2011 9:59:19 AM
GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc. today announced successful completion of whole genome maps of the German outbreak E. coli isolates, performed in cooperation with the University Hospital Münster, Germany on the Argus™ Optical Mapping System. In less than 48 hours, the company completed de novo, whole genome maps of six isolates from the outbreak and reference strains, confirming that the outbreak E. coli are clonal or genetically identical, providing the strongest evidence to date of a single source for the outbreak. In addition, comparison of the optical maps clearly shows the relationship of the current outbreak to prior outbreak strains.
|
|
|
|
|
|
|
|
|
|
|